Drugs / S6G5T-3
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04059523 | Jun 2019 → Feb 2020 | acne | Sol-Gel Technologies, Ltd. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02661958 | May 2016 → Oct 2017 | acne | Sol-Gel Technologies, Ltd. | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT03761810 | Dec 2018 → Oct 2019 | acne | Sol-Gel Technologies, Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | S6G5T-3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02661958 ↗ |
| Route | Topical | “once a day topical cream” NCT02661958 ↗ |